MHI Cultivo Medicinal SA
About the organisation
MHI Cultivo Medicinal S.A. is a fully integrated global pharmaceutical company that provides broad access to innovative and high-quality Medical Cannabis medications to patients around the globe.
MHI aims to advance medical research and development in different therapeutic areas via exploring the connection between use of cannabis plant components and improving health in patients with various medical conditions.
Wishes to contribute to symptom relief of people whose needs cannot be met through traditional drug treatments. Our teams have extensive experience in the pharmaceutical industry, and to achieve this we proudly partner with leading scientists and reputable research institutes around the globe.
Develops products in two parallel regulatory pathways – the medical cannabis route, using whole plant extractions, and the pharmaceutical route, using isolated ingredients. Controls the seed to customer value chain to ensure delivery of our highest pharma-grade quality products to patients in need.
